Nicotinamide adenine dinucleotide supplementation fails to enhance anesthetic recovery in rodents

Abstract Nicotinamide Adenine Dinucleotide (NAD+) is implicated in bioenergetics, DNA repair, and senescence. Depletion of NAD+ is associated with aging and neurodegenerative disease, prompting a growing interest in NAD+ supplementation. With rising over-the-counter use of NAD, understanding their i...

Full description

Saved in:
Bibliographic Details
Main Authors: Candida L. Goodnough, July Montoya, Erica B. Cartusciello, Erin L. Floranda, Eric R. Gross
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-83500-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544825814384640
author Candida L. Goodnough
July Montoya
Erica B. Cartusciello
Erin L. Floranda
Eric R. Gross
author_facet Candida L. Goodnough
July Montoya
Erica B. Cartusciello
Erin L. Floranda
Eric R. Gross
author_sort Candida L. Goodnough
collection DOAJ
description Abstract Nicotinamide Adenine Dinucleotide (NAD+) is implicated in bioenergetics, DNA repair, and senescence. Depletion of NAD+ is associated with aging and neurodegenerative disease, prompting a growing interest in NAD+ supplementation. With rising over-the-counter use of NAD, understanding their impact on anesthetic recovery becomes essential. This study investigates the effect of NADH, a common NAD+ precursor, on anesthesia in rodents. Baseline and post-anesthesia (1.5% isoflurane) open field and Y-maze activity were recorded in adult male and female C57BL/6 mice (n = 8–10/group). NADH (150 mg/kg, intraperitoneal) or vehicle (0.9% normal saline) were given at baseline or during anesthesia. The NADH-treated group exhibited a significant decrease in open-field activity relative to vehicle-treated. This diminished activity was reflected in reduced distance travelled and average velocity after emergence from anesthesia in the NADH-treated group. NADH treatment did not improve Y-maze performance after anesthesia, partly related to reduced locomotor activity in the NADH-treated group. This study demonstrates that NADH does not appear to hasten recovery from anesthesia. Instead, there was a depression in open-field activity and no change in Y-maze performance with NADH supplementation, indicators of locomotive and cognitive recovery in rodents. The broad implications of NAD+ in aging are likely to shape supplementation trends, highlighting the importance of understanding the potential influence of administering NAD+ on anesthetic sensitivity and recovery.
format Article
id doaj-art-7e5fbd38ef9941c38c48f0ffe80c5caf
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-7e5fbd38ef9941c38c48f0ffe80c5caf2025-01-12T12:15:51ZengNature PortfolioScientific Reports2045-23222025-01-011511810.1038/s41598-024-83500-6Nicotinamide adenine dinucleotide supplementation fails to enhance anesthetic recovery in rodentsCandida L. Goodnough0July Montoya1Erica B. Cartusciello2Erin L. Floranda3Eric R. Gross4Department of Anesthesiology, Perioperative, and Pain Medicine, School of Medicine, Stanford UniversityDepartment of Anesthesiology, Perioperative, and Pain Medicine, School of Medicine, Stanford UniversityDepartment of Anesthesiology, Perioperative, and Pain Medicine, School of Medicine, Stanford UniversityDepartment of Anesthesiology, Perioperative, and Pain Medicine, School of Medicine, Stanford UniversityDepartment of Anesthesiology, Perioperative, and Pain Medicine, School of Medicine, Stanford UniversityAbstract Nicotinamide Adenine Dinucleotide (NAD+) is implicated in bioenergetics, DNA repair, and senescence. Depletion of NAD+ is associated with aging and neurodegenerative disease, prompting a growing interest in NAD+ supplementation. With rising over-the-counter use of NAD, understanding their impact on anesthetic recovery becomes essential. This study investigates the effect of NADH, a common NAD+ precursor, on anesthesia in rodents. Baseline and post-anesthesia (1.5% isoflurane) open field and Y-maze activity were recorded in adult male and female C57BL/6 mice (n = 8–10/group). NADH (150 mg/kg, intraperitoneal) or vehicle (0.9% normal saline) were given at baseline or during anesthesia. The NADH-treated group exhibited a significant decrease in open-field activity relative to vehicle-treated. This diminished activity was reflected in reduced distance travelled and average velocity after emergence from anesthesia in the NADH-treated group. NADH treatment did not improve Y-maze performance after anesthesia, partly related to reduced locomotor activity in the NADH-treated group. This study demonstrates that NADH does not appear to hasten recovery from anesthesia. Instead, there was a depression in open-field activity and no change in Y-maze performance with NADH supplementation, indicators of locomotive and cognitive recovery in rodents. The broad implications of NAD+ in aging are likely to shape supplementation trends, highlighting the importance of understanding the potential influence of administering NAD+ on anesthetic sensitivity and recovery.https://doi.org/10.1038/s41598-024-83500-6
spellingShingle Candida L. Goodnough
July Montoya
Erica B. Cartusciello
Erin L. Floranda
Eric R. Gross
Nicotinamide adenine dinucleotide supplementation fails to enhance anesthetic recovery in rodents
Scientific Reports
title Nicotinamide adenine dinucleotide supplementation fails to enhance anesthetic recovery in rodents
title_full Nicotinamide adenine dinucleotide supplementation fails to enhance anesthetic recovery in rodents
title_fullStr Nicotinamide adenine dinucleotide supplementation fails to enhance anesthetic recovery in rodents
title_full_unstemmed Nicotinamide adenine dinucleotide supplementation fails to enhance anesthetic recovery in rodents
title_short Nicotinamide adenine dinucleotide supplementation fails to enhance anesthetic recovery in rodents
title_sort nicotinamide adenine dinucleotide supplementation fails to enhance anesthetic recovery in rodents
url https://doi.org/10.1038/s41598-024-83500-6
work_keys_str_mv AT candidalgoodnough nicotinamideadeninedinucleotidesupplementationfailstoenhanceanestheticrecoveryinrodents
AT julymontoya nicotinamideadeninedinucleotidesupplementationfailstoenhanceanestheticrecoveryinrodents
AT ericabcartusciello nicotinamideadeninedinucleotidesupplementationfailstoenhanceanestheticrecoveryinrodents
AT erinlfloranda nicotinamideadeninedinucleotidesupplementationfailstoenhanceanestheticrecoveryinrodents
AT ericrgross nicotinamideadeninedinucleotidesupplementationfailstoenhanceanestheticrecoveryinrodents